Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_assertion description "[Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_assertion evidence source_evidence_literature NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_assertion SIO_000772 21057493 NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_assertion wasDerivedFrom befree-20140225 NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_assertion wasGeneratedBy ECO_0000203 NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP610729.RAhEj_kIy7vYVLByD2myxOPF_-5RiaMxrEGqQ3pRtMQU0130_provenance.